464 related articles for article (PubMed ID: 30016968)
1. Ube2v1-mediated ubiquitination and degradation of Sirt1 promotes metastasis of colorectal cancer by epigenetically suppressing autophagy.
Shen T; Cai LD; Liu YH; Li S; Gan WJ; Li XM; Wang JR; Guo PD; Zhou Q; Lu XX; Sun LN; Li JM
J Hematol Oncol; 2018 Jul; 11(1):95. PubMed ID: 30016968
[TBL] [Abstract][Full Text] [Related]
2. TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation.
Wu H; Lu XX; Wang JR; Yang TY; Li XM; He XS; Li Y; Ye WL; Wu Y; Gan WJ; Guo PD; Li JM
Autophagy; 2019 Sep; 15(9):1506-1522. PubMed ID: 30806153
[TBL] [Abstract][Full Text] [Related]
3. Ube2v1 Positively Regulates Protein Aggregation by Modulating Ubiquitin Proteasome System Performance Partially Through K63 Ubiquitination.
Xu N; Gulick J; Osinska H; Yu Y; McLendon PM; Shay-Winkler K; Robbins J; Yutzey KE
Circ Res; 2020 Mar; 126(7):907-922. PubMed ID: 32081062
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-conjugating enzyme V variant 1 enables cellular responses toward fibroblast growth factor signaling in endothelium.
Elangovan M; Ka J; Pak B; Choi W; Oh SR; Jin SW; Yoo YJ
FASEB J; 2022 Jan; 36(1):e22103. PubMed ID: 34921695
[TBL] [Abstract][Full Text] [Related]
5. Lysine 63 ubiquitination is involved in the progression of tubular damage in diabetic nephropathy.
Pontrelli P; Conserva F; Papale M; Oranger A; Barozzino M; Vocino G; Rocchetti MT; Gigante M; Castellano G; Rossini M; Simone S; Laviola L; Giorgino F; Grandaliano G; Di Paolo S; Gesualdo L
FASEB J; 2017 Jan; 31(1):308-319. PubMed ID: 27881486
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis.
Yu L; Dong L; Li H; Liu Z; Luo Z; Duan G; Dai X; Lin Z
Oncogene; 2020 May; 39(22):4450-4464. PubMed ID: 32361710
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
8. SIRT1 suppresses colorectal cancer metastasis by transcriptional repression of miR-15b-5p.
Sun LN; Zhi Z; Chen LY; Zhou Q; Li XM; Gan WJ; Chen S; Yang M; Liu Y; Shen T; Xu Y; Li JM
Cancer Lett; 2017 Nov; 409():104-115. PubMed ID: 28923398
[TBL] [Abstract][Full Text] [Related]
9. SIRT1 promotes epithelial-mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression.
Cheng F; Su L; Yao C; Liu L; Shen J; Liu C; Chen X; Luo Y; Jiang L; Shan J; Chen J; Zhu W; Shao J; Qian C
Cancer Lett; 2016 Jun; 375(2):274-283. PubMed ID: 26975631
[TBL] [Abstract][Full Text] [Related]
10. Snail/FOXK1/Cyr61 Signaling Axis Regulates the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Huang X; Xiang L; Li Y; Zhao Y; Zhu H; Xiao Y; Liu M; Wu X; Wang Z; Jiang P; Qing H; Zhang Q; Liu G; Zhang W; Li A; Chen Y; Liu S; Wang J
Cell Physiol Biochem; 2018; 47(2):590-603. PubMed ID: 29794466
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
12. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling.
Shen ZL; Wang B; Jiang KW; Ye CX; Cheng C; Yan YC; Zhang JZ; Yang Y; Gao ZD; Ye YJ; Wang S
Oncotarget; 2016 Jun; 7(23):35092-105. PubMed ID: 27145368
[TBL] [Abstract][Full Text] [Related]
14. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer.
Zhu Y; Huang S; Chen S; Chen J; Wang Z; Wang Y; Zheng H
Cell Death Dis; 2021 May; 12(5):449. PubMed ID: 33953166
[TBL] [Abstract][Full Text] [Related]
15. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
[TBL] [Abstract][Full Text] [Related]
16. Alpha B-crystallin promotes the invasion and metastasis of colorectal cancer via epithelial-mesenchymal transition.
Shi C; Yang X; Bu X; Hou N; Chen P
Biochem Biophys Res Commun; 2017 Aug; 489(4):369-374. PubMed ID: 28506831
[TBL] [Abstract][Full Text] [Related]
17. miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT.
Chen J; Zhang H; Chen Y; Qiao G; Jiang W; Ni P; Liu X; Ma L
Exp Cell Res; 2017 Mar; 352(1):104-112. PubMed ID: 28161537
[TBL] [Abstract][Full Text] [Related]
18. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
[TBL] [Abstract][Full Text] [Related]
19. CBP mediated DOT1L acetylation confers DOT1L stability and promotes cancer metastasis.
Liu C; Yang Q; Zhu Q; Lu X; Li M; Hou T; Li Z; Tang M; Li Y; Wang H; Yang Y; Wang H; Zhao Y; Wen H; Liu X; Mao Z; Zhu WG
Theranostics; 2020; 10(4):1758-1776. PubMed ID: 32042335
[No Abstract] [Full Text] [Related]
20. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
Wu Y; Peng Y; Wu M; Zhang W; Zhang M; Xie R; Zhang P; Bai Y; Zhao J; Li A; Nan Q; Chen Y; Ren Y; Liu S; Wang J
Oncotarget; 2016 Aug; 7(32):51150-51162. PubMed ID: 27223064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
